Literature DB >> 87761

Oral prostaglandin E2 in pulmonary atresia.

J Y Coe, E D Silove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 87761     DOI： 10.1016/s0140-6736(79)92259-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Pulmonary arterial structure in pulmonary atresia after prostaglandin E2 administration.

Authors:  S G Haworth; E D Silove
Journal:  Br Heart J       Date:  1981-03

2.  Administration of E-type prostaglandins in ductus-dependent congenital heart disease.

Authors:  E D Silove
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

3.  Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.

Authors:  E D Silove; D G Roberts; J V de Giovanni
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

4.  Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.

Authors:  A Høst; S Halken; P E Andersen
Journal:  Pediatr Radiol       Date:  1988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.